Kershaw P

References (6)

Title : Effects of statins on cognitive function in patients with Alzheimer's disease in galantamine clinical trials - Winblad_2007_Drugs.Aging_24_57
Author(s) : Winblad B , Jelic V , Kershaw P , Amatniek J
Ref : Drugs & Aging , 24 :57 , 2007
Abstract : Winblad_2007_Drugs.Aging_24_57
ESTHER : Winblad_2007_Drugs.Aging_24_57
PubMedSearch : Winblad_2007_Drugs.Aging_24_57
PubMedID: 17233547

Title : The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial - Raskind_2004_Arch.Neurol_61_252
Author(s) : Raskind MA , Peskind ER , Truyen L , Kershaw P , Damaraju CV
Ref : Archives of Neurology , 61 :252 , 2004
Abstract : Raskind_2004_Arch.Neurol_61_252
ESTHER : Raskind_2004_Arch.Neurol_61_252
PubMedSearch : Raskind_2004_Arch.Neurol_61_252
PubMedID: 14967774

Title : The clinical efficacy and safety of galantamine in the treatment of Alzheimer's disease - Dengiz_2004_CNS.Spectr_9_377
Author(s) : Dengiz AN , Kershaw P
Ref : CNS Spectr , 9 :377 , 2004
Abstract : Dengiz_2004_CNS.Spectr_9_377
ESTHER : Dengiz_2004_CNS.Spectr_9_377
PubMedSearch : Dengiz_2004_CNS.Spectr_9_377
PubMedID: 15115951

Title : The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure - Mintzer_2003_Int.J.Geriatr.Psychiatry_18_292
Author(s) : Mintzer JE , Kershaw P
Ref : Int J Geriatr Psychiatry , 18 :292 , 2003
Abstract : Mintzer_2003_Int.J.Geriatr.Psychiatry_18_292
ESTHER : Mintzer_2003_Int.J.Geriatr.Psychiatry_18_292
PubMedSearch : Mintzer_2003_Int.J.Geriatr.Psychiatry_18_292
PubMedID: 12673604

Title : Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease - Coyle_2001_Biol.Psychiatry_49_289
Author(s) : Coyle J , Kershaw P
Ref : Biological Psychiatry , 49 :289 , 2001
Abstract : Coyle_2001_Biol.Psychiatry_49_289
ESTHER : Coyle_2001_Biol.Psychiatry_49_289
PubMedSearch : Coyle_2001_Biol.Psychiatry_49_289
PubMedID: 11230880

Title : A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group - Tariot_2000_Neurology_54_2269
Author(s) : Tariot PN , Solomon PR , Morris JC , Kershaw P , Lilienfeld S , Ding C
Ref : Neurology , 54 :2269 , 2000
Abstract : Tariot_2000_Neurology_54_2269
ESTHER : Tariot_2000_Neurology_54_2269
PubMedSearch : Tariot_2000_Neurology_54_2269
PubMedID: 10881251